X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (42) 42
humans (35) 35
breast cancer (32) 32
female (32) 32
index medicus (28) 28
chemotherapy (25) 25
middle aged (25) 25
breast neoplasms - drug therapy (23) 23
adult (21) 21
cancer (17) 17
disease-free survival (16) 16
further section · weitere sektionen (16) 16
aged (15) 15
chemotherapy, adjuvant (15) 15
obstetrics & gynecology (14) 14
breast neoplasms - pathology (13) 13
treatment outcome (13) 13
breast neoplasms - mortality (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
follow-up (11) 11
care and treatment (10) 10
health aspects (10) 10
prospective studies (10) 10
survival (10) 10
therapy (10) 10
further section (9) 9
trastuzumab (9) 9
adjuvant chemotherapy (8) 8
breast neoplasms - surgery (8) 8
cancer patients (8) 8
immunohistochemistry (8) 8
prognosis (8) 8
survival analysis (8) 8
tumors (8) 8
women (8) 8
adjuvant treatment (7) 7
breast neoplasms - metabolism (7) 7
clinical trials (7) 7
contents · inhalt (7) 7
gene expression (7) 7
germany (7) 7
paper (7) 7
antineoplastic agents - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
biomarkers, tumor - metabolism (6) 6
breast neoplasms - genetics (6) 6
breast neoplasms - therapy (6) 6
gene-expression (6) 6
her2 (6) 6
mastectomy (6) 6
medicine & public health (6) 6
risk (6) 6
adjuvant therapy (5) 5
combined modality therapy (5) 5
cyclophosphamide (5) 5
cyclophosphamide - administration & dosage (5) 5
doxorubicin (5) 5
drug administration schedule (5) 5
high-dose chemotherapy (5) 5
kaplan-meier estimate (5) 5
medizin (5) 5
multivariate analysis (5) 5
neoplasm staging (5) 5
randomized-trial (5) 5
recurrence (5) 5
research (5) 5
risk factors (5) 5
surgery (5) 5
young adult (5) 5
adolescent (4) 4
animals (4) 4
biomarkers, tumor (4) 4
carcinoma (4) 4
docetaxel (4) 4
drug therapy (4) 4
endocrine therapy (4) 4
epirubicin - administration & dosage (4) 4
erbb-2 protein (4) 4
genes (4) 4
high-risk (4) 4
invasiveness (4) 4
original article · originalarbeit (4) 4
ovarian cancer (4) 4
paclitaxel (4) 4
paclitaxel - administration & dosage (4) 4
patients (4) 4
phase-iii (4) 4
proportional hazards models (4) 4
randomized controlled trials as topic (4) 4
review article · übersichtsarbeit (4) 4
risk assessment (4) 4
risk groups (4) 4
transplantation (4) 4
anthracyclines (3) 3
antineoplastic agents - pharmacology (3) 3
biomarkers (3) 3
biomarkers, tumor - analysis (3) 3
biopsy (3) 3
breast (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Geburtshilfe und Frauenheilkunde, ISSN 0016-5751, 2002, Volume 62, Issue 4, pp. 388 - 389
Journal Article
Im Focus Onkologie, ISSN 1435-7402, 12/2018, Volume 21, Issue 12, pp. 39 - 43
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2005, Volume 353, Issue 16, pp. 1659 - 1672
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2013, Volume 110, Issue 41, pp. 16580 - 16585
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 10/2017, Volume 165, Issue 3, pp. 573 - 583
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 1/2019, Volume 173, Issue 2, pp. 429 - 438
Journal Article
ANNALS OF SURGICAL ONCOLOGY, ISSN 1068-9265, 08/2019, Volume 26, Issue 8, pp. 2435 - 2443
BackgroundIn breast cancer, completion axillary lymph node dissection (cALND) was previously recommended for patients with at least one tumour-affected... 
SURGERY | TRIAL | MULTICENTER | ONCOLOGY | BIOPSY | FOLLOW-UP | OUTCOMES | RADIOTHERAPY | Lumpectomy | Care and treatment | Usage | Cancer patients | Analysis | Oncology, Experimental | Breast cancer | Research | Cancer
Journal Article
The Lancet, ISSN 0140-6736, 12/2005, Volume 366, Issue 9501, pp. 1935 - 1944
Journal Article
Genes, Chromosomes and Cancer, ISSN 1045-2257, 03/2019, Volume 58, Issue 3, pp. 175 - 185
HER2‐positive breast cancer is defined by amplification or overexpression of the HER2/ERBB2 oncogene and accounts for about 15% of breast cancer cases. Somatic... 
lobular breast cancer | HER2/ERBB2 mutation | recurrence score | Oncotype DX | PIK3CA MUTATIONS | AMPLIFICATION | HER2 MUTATIONS | ONCOLOGY | GENETICS & HEREDITY | NERATINIB | CARCINOMA IN-SITU | PORTRAITS | Phenotypes | Sequences | Invasiveness | Estrogens | Organs | Health risks | Estrogen receptors | Histology | Breast cancer | Metastasis | Tissues | ErbB-2 protein | E-cadherin | Metastases | Next-generation sequencing | Breast | Skin | Mutation | Cancer | Tumors
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 5/2019, Volume 175, Issue 1, pp. 265 - 266
The article Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the... 
Medicine & Public Health | Oncology | Care and treatment | Cancer patients | Chemotherapy | Breast cancer | Cancer
Journal Article